However, research has demonstrated that AR and the androgen signaling pathway play a role in the etiology and progression of bladder cancer [62], and combining antiandrogens with BCG immunotherapy could improve its efficacy [63,64,65]. The gene discussed is AR; the disease is urinary bladder cancer.